Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadao Ishida

Showing results (11-20 of 151) with videos related to

Pageof 16
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 21, 2013
[II. Immunomodulation for multiple myeloma]Tadao Ishida
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 26, 2013
[Multiple myeloma: chromosomal abnormalities, clinical features and prognosis]Tadao Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 12, 2013
[Triplets therapy for the patients of multiple myeloma]Tadao Ishida
Japanese Journal of Clinical Oncology|June 13, 2019
Immunomodulatory drugs in the treatment of multiple myelomaYu Abe, Tadao Ishida
Japanese Journal of Clinical Oncology|August 14, 2018
Proteasome inhibitors for multiple myelomaKiyoshi Okazuka, Tadao Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2002
[The expression technology of chimeric and humanized antibodies]Tadao Ishida, Kohzoh Imai
Journal of Gastroenterology|August 9, 2003
The management of gastrointestinal infections caused by cytomegalovirusTadao Ishida, Kohzoh Imai
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2002
[Monoclonal antibody therapy for disorders of hemostasis and coagulation]Susumu Nishimura, Tadao Ishida, Kohzoh Imai
Cancer Science|August 10, 2004
Monoclonal antibodies as effective therapeutic agents for solid tumorsYuji Hinoda, Shigeru Sasaki, Tadao Ishida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 6, 2018
[Successful treatment with thalidomide-combined therapy in an amyloidosis-complicated multiple myeloma patient refractory to bortezomib, lenalidomide, and pomalidomide]Yuka Aoki, Toshiaki Hayashi, Hiroshi Ikeda, et al.
Pageof 16

Showing results (11-20 of 151) with videos related to

Sort By:
Pageof 16
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 21, 2013
[II. Immunomodulation for multiple myeloma]Tadao Ishida
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 26, 2013
[Multiple myeloma: chromosomal abnormalities, clinical features and prognosis]Tadao Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 12, 2013
[Triplets therapy for the patients of multiple myeloma]Tadao Ishida
Japanese Journal of Clinical Oncology|June 13, 2019
Immunomodulatory drugs in the treatment of multiple myelomaYu Abe, Tadao Ishida
Japanese Journal of Clinical Oncology|August 14, 2018
Proteasome inhibitors for multiple myelomaKiyoshi Okazuka, Tadao Ishida
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2002
[The expression technology of chimeric and humanized antibodies]Tadao Ishida, Kohzoh Imai
Journal of Gastroenterology|August 9, 2003
The management of gastrointestinal infections caused by cytomegalovirusTadao Ishida, Kohzoh Imai
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2002
[Monoclonal antibody therapy for disorders of hemostasis and coagulation]Susumu Nishimura, Tadao Ishida, Kohzoh Imai
Cancer Science|August 10, 2004
Monoclonal antibodies as effective therapeutic agents for solid tumorsYuji Hinoda, Shigeru Sasaki, Tadao Ishida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 6, 2018
[Successful treatment with thalidomide-combined therapy in an amyloidosis-complicated multiple myeloma patient refractory to bortezomib, lenalidomide, and pomalidomide]Yuka Aoki, Toshiaki Hayashi, Hiroshi Ikeda, et al.
Pageof 16